These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 38874879)

  • 1. APPaRENT 3: Asthma Patients' and Physicians' Perspectives on the Burden and Management of Asthma in Seven Countries.
    Aggarwal B; Al-Moamary M; Allehebi R; Alzaabi A; Al-Ahmad M; Amin M; Damayanti T; Van Tho N; Quyen PTL; Sriprasart T; Poachanukoon O; Yu-Lin AB; Ismail AI; Limpin MEB; Koenig S; Levy G; Phansalkar A; Rafih F; Silvey M; Miriams L; Milligan G
    Adv Ther; 2024 Aug; 41(8):3089-3118. PubMed ID: 38874879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate-Severe Asthma: A Clinical Modelling and Simulation Study.
    Paggiaro P; Garcia G; Roche N; Verma M; Plank M; Oosterholt S; Duong JK; Majumdar A; Della Pasqua O
    Adv Ther; 2024 Nov; 41(11):4065-4088. PubMed ID: 39240503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.
    Chapman KR; Canonica GW; Lavoie KL; Nenasheva N; Garcia G; Bosnic-Anticevich S; Bourdin A; Cano MCD; Abhijith PG; Aggarwal B
    Respir Med; 2022 Sep; 201():106948. PubMed ID: 36029695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma patients' and physicians' perspectives on the burden and management of asthma: Post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
    Canonica GW; Domingo C; Lavoie KL; Kaliasethi A; Khan SQ; Majumdar A; Fulmali S
    Respir Med; 2024 Jun; 227():107637. PubMed ID: 38636683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe Asthma.
    Garcia G; van Dijkman SC; Pavord I; Singh D; Oosterholt S; Fulmali S; Majumdar A; Della Pasqua O
    Adv Ther; 2024 Aug; 41(8):3196-3216. PubMed ID: 38916810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
    Kew KM; Karner C; Mindus SM; Ferrara G
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD009019. PubMed ID: 24343671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, practice pattern and attitude toward asthma management amongst physicians from Nepal, Malaysia, Lebanon, Myanmar and Morocco.
    Chokhani R; Razak A; Waked M; Naing W; Bakhatar A; Khorani U; Gaur V; Gogtay J
    J Asthma; 2021 Jul; 58(7):979-989. PubMed ID: 32174204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
    Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
    Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials.
    van Dijkman SC; Yorgancıoğlu A; Pavord I; Brusselle G; Pitrez PM; Oosterholt S; Fumali S; Majumdar A; Della Pasqua O
    Adv Ther; 2024 Mar; 41(3):1201-1225. PubMed ID: 38296921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
    Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
    Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma patients' and physicians' perspectives on the burden and management of asthma.
    Chapman KR; An L; Bosnic-Anticevich S; Campomanes CM; Espinosa J; Jain P; Lavoie KL; Li J; Butta AK
    Respir Med; 2021 Sep; 186():106524. PubMed ID: 34265629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of inhalers in mild-to-moderate asthma: systematic review and network meta-analysis.
    Park HJ; Huh JY; Lee JS; Lee JS; Oh YM; Lee SW
    Sci Rep; 2022 Apr; 12(1):5949. PubMed ID: 35396495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
    Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
    JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C; Naya I; Ekelund J
    Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid plus β
    Wang G; Zhang X; Zhang HP; Wang L; Kang Y; Barnes PJ; Wang G
    Respir Res; 2017 Dec; 18(1):203. PubMed ID: 29207999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial.
    Krings JG; Wojcik KM; Chen V; Sekhar TC; Harris K; Zulich A; Sumino K; Brownson R; Lenze E; Castro M
    Trials; 2022 Dec; 23(1):975. PubMed ID: 36471430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct healthcare costs associated with management of asthma: comparison of two treatment regimens in Indonesia, Thailand and Vietnam.
    Aggarwal B; Jones PW; Yunus F; Lan LTT; Boonsawat W; Ismaila A; Ascioglu S
    J Asthma; 2022 Jun; 59(6):1213-1220. PubMed ID: 33764239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.